Northern Trust’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$518K Sell
254,425
-211,353
-45% -$430K ﹤0.01% 3633
2025
Q1
$759K Buy
465,778
+246,721
+113% +$402K ﹤0.01% 3395
2024
Q4
$401K Buy
219,057
+13,269
+6% +$24.3K ﹤0.01% 3735
2024
Q3
$1.19M Buy
205,788
+144,676
+237% +$836K ﹤0.01% 3279
2024
Q2
$494K Buy
61,112
+12,060
+25% +$97.4K ﹤0.01% 3516
2024
Q1
$681K Buy
49,052
+2,744
+6% +$38.1K ﹤0.01% 3461
2023
Q4
$283K Buy
46,308
+6,391
+16% +$39.1K ﹤0.01% 3748
2023
Q3
$186K Buy
39,917
+1,104
+3% +$5.15K ﹤0.01% 3839
2023
Q2
$208K Sell
38,813
-150,838
-80% -$808K ﹤0.01% 3817
2023
Q1
$1.87M Sell
189,651
-5,854
-3% -$57.6K ﹤0.01% 2971
2022
Q4
$3.66M Buy
195,505
+13,870
+8% +$260K ﹤0.01% 2673
2022
Q3
$3.76M Buy
181,635
+15,619
+9% +$323K ﹤0.01% 2659
2022
Q2
$3.45M Buy
166,016
+8,362
+5% +$174K ﹤0.01% 2746
2022
Q1
$6.79M Sell
157,654
-6,173
-4% -$266K ﹤0.01% 2390
2021
Q4
$9.81M Sell
163,827
-4,204
-3% -$252K ﹤0.01% 2242
2021
Q3
$14.4M Sell
168,031
-4,360
-3% -$375K ﹤0.01% 2022
2021
Q2
$19.2M Sell
172,391
-4,050
-2% -$451K ﹤0.01% 1915
2021
Q1
$19.6M Buy
176,441
+17,800
+11% +$1.98M ﹤0.01% 1837
2020
Q4
$16.8M Sell
158,641
-1,044
-0.7% -$111K ﹤0.01% 1916
2020
Q3
$22.2M Buy
159,685
+2,901
+2% +$404K ﹤0.01% 1548
2020
Q2
$50.7M Buy
156,784
+55,493
+55% +$17.9M 0.01% 886
2020
Q1
$9.04M Buy
101,291
+14,058
+16% +$1.26M ﹤0.01% 1935
2019
Q4
$3.46M Sell
87,233
-8,909
-9% -$353K ﹤0.01% 2806
2019
Q3
$2.36M Buy
96,142
+9,621
+11% +$237K ﹤0.01% 3008
2019
Q2
$3.05M Sell
86,521
-3,413
-4% -$120K ﹤0.01% 2825
2019
Q1
$4.03M Buy
89,934
+2,558
+3% +$114K ﹤0.01% 2680
2018
Q4
$4.19M Buy
87,376
+898
+1% +$43.1K ﹤0.01% 2614
2018
Q3
$5.77M Buy
86,478
+912
+1% +$60.9K ﹤0.01% 2608
2018
Q2
$4.03M Buy
85,566
+2,796
+3% +$132K ﹤0.01% 2799
2018
Q1
$4.68M Sell
82,770
-2,004
-2% -$113K ﹤0.01% 2628
2017
Q4
$4.2M Sell
84,774
-2,114
-2% -$105K ﹤0.01% 2710
2017
Q3
$6.61M Buy
86,888
+12,182
+16% +$927K ﹤0.01% 2454
2017
Q2
$7.03M Buy
74,706
+2,030
+3% +$191K ﹤0.01% 2405
2017
Q1
$5.77M Buy
72,676
+3,820
+6% +$303K ﹤0.01% 2467
2016
Q4
$5.73M Buy
68,856
+1,216
+2% +$101K ﹤0.01% 2465
2016
Q3
$7.57M Sell
67,640
-255
-0.4% -$28.5K ﹤0.01% 2250
2016
Q2
$7.53M Sell
67,895
-1,334
-2% -$148K ﹤0.01% 2202
2016
Q1
$7.24M Buy
69,229
+640
+0.9% +$66.9K ﹤0.01% 2185
2015
Q4
$5.53M Buy
68,589
+2,323
+4% +$187K ﹤0.01% 2405
2015
Q3
$4.6M Buy
66,266
+1,000
+2% +$69.4K ﹤0.01% 2487
2015
Q2
$6.39M Buy
65,266
+8,911
+16% +$872K ﹤0.01% 2361
2015
Q1
$5.52M Buy
56,355
+1,763
+3% +$173K ﹤0.01% 2444
2014
Q4
$6.01M Sell
54,592
-802
-1% -$88.4K ﹤0.01% 2383
2014
Q3
$6.55M Buy
55,394
+41,227
+291% +$4.87M ﹤0.01% 2333
2014
Q2
$1.84M Buy
14,167
+6,039
+74% +$783K ﹤0.01% 3131
2014
Q1
$1.3M Buy
8,128
+634
+8% +$101K ﹤0.01% 3320
2013
Q4
$1.04M Buy
7,494
+1,313
+21% +$183K ﹤0.01% 3369
2013
Q3
$615K Buy
6,181
+1,998
+48% +$199K ﹤0.01% 3422
2013
Q2
$160K Buy
+4,183
New +$160K ﹤0.01% 3706